Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;89(10):e202400413.
doi: 10.1002/cplu.202400413. Epub 2024 Aug 19.

Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism

Affiliations
Free article

Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole Bioisosterism

Eleonora Colombo et al. Chempluschem. 2024 Oct.
Free article

Abstract

Epothilones are 16-membered macrolides that act as microtubule-targeting agents to tackle cancer. Many synthetic analogues have been investigated for their activity, yet often based on macrolide structures. A notable exception is Ixabepilone, an azalide whose metabolic stability and pharmacokinetics are significantly improved. Exploiting the amide-triazole bioisosterism, in this work we report the synthesis of the first generation of epothilones lacking the macrolide or azalide structure, with the ester or amide linkage replaced by a triazole unit. Together with the synthesis of this new analogue, computational and biological evaluations have been performed too.

Keywords: Epothilone; Ixabepilone; Macrolide; Triazole; Tubulin.

PubMed Disclaimer

References

    1. N. M. Verrills, C. L. Flemming, M. Liu, M. T. Ivery, G. S. Cobon, M. D. Norris, M. Haber, M. Kavallaris, Chem. Biol. 2003, 10, 597.
    1. K.-H. Altmann, B. Pfeiffer, S. Arseniyadis, B. A. Pratt, K. C. Nicolaou, ChemMedChem 2007, 396.
    1. C. F. Brogdon, F. Y. Lee, R. M. Canetta, Anticancer Drugs 2014, 25, 599.
    1. K.-H. Altmann, F. Z. Gaugaz, R. Schiess, Mol. Divers. 2011, 15, 383.
    1. K.-H. Altmann, K. Memmert, Prog. Drug Res. 2008, 66, 275.

MeSH terms

Grants and funding